The UC Davis MIND Institute is launching a $4 million research program aimed at finding transformative therapies for ADNP syndrome, a rare genetic condition. A group of interdisciplinary researchers will evaluate multiple gene therapies for possible use.
Half of all women experience a false positive mammogram after 10 years of annual breast cancer screening with 3D mammography, a UC Davis-led study estimates. This risk was lower for women who had mammograms every other year. 3D screening showed slightly lower false positive results than standard mammography.
In a first of its kind clinical trial led by UC Davis Health, HOPE-2 showed that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
The UC Davis MIND Institute’s Leadership Education in Neurodevelopmental and Related Disabilities program is recruiting. Self-advocates, family members, researchers and clinicians who are passionate about improving the lives of people with autism and other neurodevelopmental disabilities are invited to apply.
The UC Davis MIND Institute has received funding from the Patient-Centered Outcomes Research Institute to create community partnerships to increase equity in research. The goal is to create a network that includes individuals with intellectual and developmental disabilities from diverse communities.
Researchers at the UC Davis MIND Institute have identified a gene linked to fetal brain development and autism. Their work shows that the gene is influenced by the mother’s early prenatal vitamins use and placental oxygen levels.
A long-term study by UC Davis MIND Institute researchers finds significant changes in brain development linked to anxiety in autistic children. The study, which included brain scans and interviews, also provides new evidence that supports forms of anxiety specific to autism.
A new UC Davis Health study found that taking bile acids or treatments that regulate their production may help control inflammation caused by psoriasis, a chronic skin condition.
The MIND Institute’s RISE-UP program is recruiting undergraduate students for its summer program. The unique opportunity is focused on students interested in serving historically underserved communities. They’ll learn more about research, clinical care, community support, neurodevelopmental disabilities and social justice.
A study led by UC Davis has found significant gut bacteria profile differences between Black and white women, even after accounting for their insulin sensitivity status.
A new study by researchers with the UC Davis Comprehensive Cancer Center shows Latino smokers on Medi-Cal are still not getting the cessation information they need to help them get treatment for tobacco addiction.
The UC Davis Health Cancer Care Network is adding Marshall Medical Center as its newest member. The cancer services affiliation allows Marshall patients in El Dorado County access to the renowned UC Davis Comprehensive Cancer Center to ensure they have the latest diagnostic and treatment options.
The associate director for the clinical research program at UC Davis Comprehensive Cancer Center embarks on new leadership role in early 2022 as CEO of the International Association for the Study of Lung Cancer
The UC Davis Comprehensive Cancer Center director has appointed a new medical director to lead the nationally recognized Thoracic Oncology Program. Jonathan Wesley Riess replaces David. R. Gandara who will co-direct a new center in experimental cancer therapeutics.
UC Davis Health researchers showed that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease, an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation.
Orin Bloch is the new co-leader of UC Davis Comprehensive Cancer Center Biomedical Technology Program, which works to further innovative advances in cancer research, diagnosis, and therapy. His appointment is effective Dec. 1, 2021.
A UC Davis Health team has developed a new positron emission tomography (PET) scan imaging-based tool to detect liver inflammation in patients affected with non-alcoholic fatty liver disease. The condition affects nearly a third of the population of the United States.
A new article published in The New England Journal of Medicine suggests that secondary antibodies known as “anti-idiotype antibodies” could be responsible for some of the side effects of COVID-19 vaccines and the symptoms of long-haul COVID.
A new UC Davis MIND Institute study suggests that parent-led language testing delivered via telehealth is effective for children with autism. The format was tested in both English and Spanish-speaking families and may provide a new way to measure the efficacy of treatments.
UC Davis Health scientists developed a new tool to translate cardiac studies from animal models to humans. The tool will help in better understanding arrhythmia and other heart conditions and support the search for effective cardiac therapies.
New study results show compliance with smoke- and tobacco-free policies on college campuses could be more effective with the rollout of a Tobacco Tracker that can also influence behavior and attitudes.
The National Cancer Institute renewed the “comprehensive” designation of the UC Davis Comprehensive Cancer Center in recognition of its breadth and depth in cancer research, clinical care, cancer control and population sciences.
Unusual visual inspection of objects in infants may precede the development of the social symptoms characteristic of autism syndrome disorder, a UC Davis Health study has found.
A UC Davis Health study published in JAMA found a 68% increase in overdose events and a doubling of mental health crises among patients who were on stable opioid therapy but saw their doses tapered.
The UC Davis Comprehensive Cancer Center received a $50,000 grant from the Safeway Foundation. The funding will allow researcher Mili Arora to study whether the spice turmeric can provide pain relief for breast cancer patients on oral anti-estrogen drugs.
Department of Radiology Chair Elizabeth Morris, with the UC Davis Comprehensive Cancer Center, was awarded a Susan G. Komen® grant to develop artificial intelligence models to predict breast cancer risk at a more personalized level
A new study confirms the low likelihood that coronavirus contamination on hospital surfaces is infectious. The study is the original report on recovering near-complete SARS-CoV-2 genome sequences directly from surface swabs.
A groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body’s antiviral immunity, and restore the gut’s lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies.
Diet rich in sugar and fat leads to disruption in the gut’s microbial culture and contributes to inflammatory skin diseases such as psoriasis. Research shows that switching to a more balanced diet restores the gut’s health and suppresses inflammation.
The new medical director for the UC Davis Comprehensive Cancer Center Office of Clinical Research is Dr. Edward Kim who steps into his new position e on July 1, 2021.
The UC Davis Clinical Translational Science Center (CTSC) received notice of its third National Institutes of Health (NIH) award renewal. The 5-year award, almost $33 million, provides critical funding to continue CTSC’s essential services for the UC Davis research community.
A new study shows that two-thirds of Californians don’t know about a law designed to prevent a person at risk of hurting themselves or others from possessing or purchasing firearms or ammunition. More than 80% of survey participants were supportive once they read about this law.
An international team of researchers, led by UC Davis Health, developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory disease affecting the joints.
UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.
UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.
A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a 20-minute COVID-19 test. The method pairs a mass spectrometer with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs. A recent study published in Nature Scientific Reports shows the test to be 98.3% accurate for positive COVID-19 tests and 96% for negative tests.
A new study, conducted by three UC Davis Comprehensive Cancer Center researchers, studies young adult smoking trends three years after the start of California’s law raising the sales age of tobacco to 21.
In one of the largest research projects of its kind, a new study published in JAMA Network Open looks at nearly 900,000 individuals and close to 2 million mammograms to come up with a new way to detect the most breast cancer cases with the fewest exams.
UC Davis Health researchers studying executive control in adolescents and young adults with autism have published new research that suggests a unique approach, rather than impairment.
The UC Davis MIND Institute and the National Fragile X Foundation have launched an international registry of people carrying the fragile X premutation. The goal is to facilitate and encourage research about the genetic condition to improve understanding and treatment.
UC Davis MIND Institute researchers used machine learning to crunch 10,000 autoantibody pattern combinations to identify maternal biomarkers associated with a sub-type of autism. The findings have implications for early diagnosis and intervention.
A survey of Californians finds that exposure to violence has pervasive social and emotional impacts on people, especially when firearms are involved.
Wildfire smoke contains microbes, infectious agents that might cause diseases. In a perspective piece published in Science, researchers at UC Davis Health and the University of Idaho proposed a multidisciplinary approach to study the health impacts of microbes carried by wildfire smokes.
Researchers found that a long-accepted theory about brain size in some children with autism may not be true. In a separate study, they linked development of white matter with changes in autism symptom severity.
An enzyme in the colon lining releases hydrogen peroxide – a known disinfecting compound- to protect the body from gut microbial communities. Findings from the UC Davis Health study points to importance of considering a different approach to treating gut inflammation and bacterial imbalance in the colon.
UC Davis Health will launch a COVID-19 clinical trial with Novavax to test a new coronavirus vaccine. This vaccine has an important advantage: liquid state storage that allows for distribution using standard vaccine channels, unlike the Pfizer and Moderna vaccines that must be stored at subzero temperature.
A new study by the UC Davis MIND Institute finds a connection between gestational age and ADHD in children with Down syndrome. An earlier gestational age is linked to higher ADHD symptoms later in childhood.
In a case series of three teen patients, UC Davis Health pediatricians present the common manifestations of COVID-19 and lung injury due to vaping (EVALI). As EVALI and COVID-19 share many symptoms, it is critical for health providers to get the vaping history of teenagers with unexplained breathing problems.
Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term health complications after treatment, a study led by UC Davis Comprehensive Cancer Center researchers has found. The most common complications were cardiovascular, endocrine and respiratory diseases. The complications - known as late effects - were more present among non-white AYA patients and those living in more deprived neighborhoods.
UC Davis Health is one of only a handful of health systems in the U.S. to launch a Post-COVID-19 Clinic to care for long-haul COVID patients whose symptoms go on and on, sometimes for months, with no clear explanation or avenue for treatment.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right